ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "B cells and antibodies"

  • Abstract Number: 1750 • ACR/ARHP Annual Meeting 2012

    Phosphoprotein Changes Induced with Epratuzumab, an Antibody Targeting CD22 On B Cells

    S. Lumb1, N. Torbett2, I. Vandrell2, H. Turner2, M. Page1, P. Hales1, A. Maloney1, B. Vanhaesebroeck2, P. Cutillas2 and A. Shock1, 1UCB Pharma, Slough, United Kingdom, 2Activiomics Ltd., London, United Kingdom

    Background/Purpose: Epratuzumab is a monoclonal antibody targeting CD22 that is currently in phase III clinical trials in systemic lupus erythematosus (SLE) patients. CD22 is found…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology